[1] |
Yasuda Y,Fujita Y,Matsuo T,et al.Erythropoietin regulates tumour growth of human malignancies[J].Carcinogenesis,2003,24(6):1021-9.
|
[2] |
Bose C,Udupa KB.Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals[J].Am J Physiol Cell Physiol,2008,295(2):C394-405.
|
[3] |
Acs G,Chen M,Xu X,et al.Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells[J].Cancer Lett,2004,214(2):243-51.
|
[4] |
Belenkov AI,Shenouda G,Rizhevskaya E,et al.Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin[J].Mol Cancer Ther,2004,3(12):1525-32.
|
[5] |
Yu JM,Xu ZF.Clinical oncology tongjian[M].Ji′nan:Shandong Science and Technology Press,2004:1194-207. [于金明,徐忠法.肿瘤临床通鉴[M].济南:山东科学技术出版社,2004:1194-207.]
|
[6] |
Gupta S,Singh PK,Bisht SS,et al.Role of recombinant human erythropoietin in patients of advanced cervical cancer treated “by chemoradiotherapy”[J].Cancer Biol Ther,2009,8(1):13-7.
|
[7] |
Feldman L,Wang Y,Rhim JS,et al.Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells[J].Prostate,2006,66(2):135-45.
|
[8] |
Belenkov AI,Shenouda G,Rizhevskaya E,et al.Erythropoietin induces cancer cell resistance to ionizing radiation and to cisplatin[J].Mol Cancer Ther,2004,3(12):1525-32.
|
[9] |
Solar P,Feldman L,Jeong JY,et al.Erythropoietin treatment of human ovarian cancer cells results in enhanced signaling and a paclitaxel-resistant phenotype[J].Int J Cancer,2008,122(2):281-8.
|
[10] |
Westphal G,Niederberger E,Blum C,et al.Erythropoietin and G-CSF receptors in human tumor cells:expression and aspects regarding functionality [J].Tumori,2002,88(2):150-9.
|
[11] |
LaMontagne KR,Butler J,Marshall DJ,et al.Recombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma models[J].Mol Cancer Ther,2006,5(2):347-55.
|
[12] |
Katz O,Barzilay E,Skaat A,et al.Erythropoietin induced tumour mass reduction in murine lymphoproliferative models[J].Acta Haematol,2005,114(3):177-9.
|
[13] |
Sigounas G,Sallah S,Sigounas VY.Erythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer model[J].Cancer Lett,2004,214(2):171-9.
|
[14] |
Tóvári J,Gilly R,Rásó E,et al.Recombinant human erythropoietin alpha targets intratumoral blood vessels,improving chemotherapy in human xenograft models[J].Cancer Res,2005,65(16):7186-93.
|
[15] |
Silva M,Benito A,Sanz C,et al.Erythropoietin can induce the expression of bcl-x(L)through Stat5 in erythropoietindependent progenitor cell lines[J].J Biol Chem,1999,274(32):22165-9.
|
[16] |
Silva M,Grillot D,Benito A,et al.Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2[J].Blood,1996,88(5):1576-82.
|
[17] |
Batra S,Perelman N,Luck LR,et al.Pediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survival[J].Lab Invest,2003,83(10):1477-87.
|